U.S. Biotech Firms Israeli Chief Medical Officer Says Its COVID-19 Vaccine Will Be Ready at End of the Year
The Israeli chief medical officer of the Massachusetts-based biotech firm Moderna told Israeli television on May 18 that the company’s COVID-19 vaccine likely will be able to reach the U.S. market at the end of 2020 or beginning of 2021.
The Times of Israel reported that Dr. Tal Zaks, Moderna’s chief medical officer, said that the vaccine had been used on 45 volunteers in March; none of the volunteers suffered from any serious side effects. Moderna learned on May 18 that eight of the volunteers who received two doses of the vaccine developed more antibodies than seen in people who recovered from the virus.
